Prostate cancer, a condition affecting countless men worldwide, has long been synonymous with aggressive treatments like surgery and radiation. However, the landscape of prostate cancer care is evolving, offering new hope to patients seeking alternative, minimally invasive options. The groundbreaking technique is known as high-intensity focused ultrasound (HIFU).
Unlike traditional treatments that target the entire gland, HIFU's innovation lies in its precision. It selectively treats cancerous tissue while sparing the surrounding healthy tissue, drastically reducing the risk of common side effects such as urinary incontinence and erectile dysfunction.
Not all prostate cancers require the whole gland to be treated, making HIFU a valuable option. The ideal candidates are those with early-stage cancer confined to the prostate that’s visible on an MRI or ultrasound.
When it comes to recovery, HIFU typically takes one to three hours, and patients often go home the same day. Temporary catheterization and irritative urinary symptoms are expected initially but typically improve within a few weeks.
HIFU success rates show that with well-selected patients, 70 to 80 percent have no cancer detected during a follow-up biopsy. However, this presents an opportunity for progressive therapy if needed.
The hope is bright for the future of focal therapies like HIFU in prostate cancer treatment. As medical technology and equipment continue to improve, more types and locations of lesions will qualify for this treatment. This innovative technique is changing the landscape of prostate cancer treatment, and while HIFU may not be suitable for all, it provides new hope for those seeking precise and effective treatment options.
If you or a loved one is dealing with prostate cancer, we recommend consulting with a knowledgeable health care professional who can provide a range of therapies. The future of prostate cancer treatment is evolving, and HIFU is a shining example of progress in action.
For more information, call CHI Memorial Urology Associates at (423) 697-0072.
Lori, her daughter, and a group of friends participated in CHI Memorial Foundation’s River City Ribbon Run in April 2023 to honor a friend who had recently passed away from a tumor that had been left undetected until a month prior to his passing. Thi...
Read More
Geraldine’s story is a testament to the importance of regular lung screenings and confronting fear.
Read More
A brain tumor refers to an abnormal growth of cells within the brain or its surrounding structures. These tumors can be either benign (non-cancerous) or malignant (cancerous), and they arise from the uncontrolled division and multiplication of cells ...
Read More